• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I类抗心律失常药物西苯唑啉:肥厚性梗阻性心肌病药物治疗的新方法。

Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy.

作者信息

Hamada M, Shigematsu Y, Ikeda S, Hara Y, Okayama H, Kodama K, Ochi T, Hiwada K

机构信息

Second Department of Internal Medicine, Ehime University School of Medicine, Japan.

出版信息

Circulation. 1997 Sep 2;96(5):1520-4. doi: 10.1161/01.cir.96.5.1520.

DOI:10.1161/01.cir.96.5.1520
PMID:9315541
Abstract

BACKGROUND

The class Ia antiarrhythmic drug disopyramide relieves the outflow tract obstruction of hypertrophic obstructive cardiomyopathy (HOCM). Disopyramide, however, has several adverse effects, such as dysuria and thirst, resulting from its anticholinergic activity. A new class Ia antiarrhythmic drug, cibenzoline, has little anticholinergic activity. The aim of this study is to elucidate whether cibenzoline attenuates left ventricular pressure gradient (LVPG) in patients with HOCM.

METHODS AND RESULTS

Ten patients with HOCM (mean age, 59+/-12 years) participated in this study. LVPG and left ventricular functions were measured before and 2 hours after administration of a single oral dose of 150 or 200 mg cibenzoline. LVPG decreased from 123+/-60 to 39+/-33 mm Hg (P=.0026). The E/A ratio in transmitral Doppler flow increased from 1.20+/-0.84 to 2.00+/-1.72 (P=.029). Isovolumic relaxation time increased from 73+/-16 to 101+/-23 ms (P=.0026). Left ventricular diastolic dimension remained unchanged, but left ventricular systolic dimension enlarged significantly, from 21.6+/-2.4 to 26.2+/-3.3 mm (P=.0004). Fractional shortening decreased from 47.6+/-6.1% to 34.6+/-8.8% (P=.0007). Left ventricular ejection time index decreased significantly, and preejection period index increased in all the patients. Decreased LVPG remained maintained even in the long-term treatment with cibenzoline. Conclusions These results indicate that cibenzoline can markedly attenuate LVPG in patients with HOCM. A decrease in myocardial contractility seems to be closely related to a marked decrease in LVPG.

摘要

背景

I a类抗心律失常药物双异丙吡胺可缓解肥厚性梗阻性心肌病(HOCM)的流出道梗阻。然而,双异丙吡胺因其抗胆碱能活性会产生多种不良反应,如排尿困难和口渴。一种新型I a类抗心律失常药物西苯唑啉几乎没有抗胆碱能活性。本研究的目的是阐明西苯唑啉是否能减轻HOCM患者的左心室压力阶差(LVPG)。

方法与结果

10例HOCM患者(平均年龄59±12岁)参与了本研究。在单次口服150或200 mg西苯唑啉前及给药后2小时测量LVPG和左心室功能。LVPG从123±60 mmHg降至39±33 mmHg(P = 0.0026)。二尖瓣血流频谱E/A比值从1.20±0.84增至2.00±1.72(P = 0.029)。等容舒张时间从73±16 ms增至101±23 ms(P = 0.0026)。左心室舒张末期内径保持不变,但左心室收缩末期内径显著增大,从21.6±2.4 mm增至26.2±3.3 mm(P = 0.0004)。射血分数从47.6±6.1%降至34.6±8.8%(P = 0.0007)。所有患者的左心室射血时间指数显著降低,射血前期指数增加。即使长期使用西苯唑啉,LVPG降低仍得以维持。结论这些结果表明,西苯唑啉可显著减轻HOCM患者的LVPG。心肌收缩力降低似乎与LVPG显著降低密切相关。

相似文献

1
Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy.I类抗心律失常药物西苯唑啉:肥厚性梗阻性心肌病药物治疗的新方法。
Circulation. 1997 Sep 2;96(5):1520-4. doi: 10.1161/01.cir.96.5.1520.
2
Impact of chronic use of cibenzoline on left ventricular pressure gradient and left ventricular remodeling in patients with hypertrophic obstructive cardiomyopathy.长期使用西苯唑啉对肥厚性梗阻性心肌病患者左心室压力梯度及左心室重构的影响
J Cardiol. 2016 Mar;67(3):279-86. doi: 10.1016/j.jjcc.2015.05.014.
3
Pharmacogenetic interactions between Angiotensin-converting enzyme insertion/deletion polymorphism and response to cibenzoline in patients with hypertrophic obstructive cardiomyopathy.血管紧张素转换酶插入/缺失多态性与西布曲明在肥厚型梗阻性心肌病患者中的反应的药物遗传学相互作用。
J Cardiovasc Pharmacol. 2010 May;55(5):506-10. doi: 10.1097/FJC.0b013e3181d8bc4b.
4
Cibenzoline improves coronary flow velocity reserve in patients with hypertrophic obstructive cardiomyopathy.西苯唑啉可改善肥厚性梗阻性心肌病患者的冠状动脉血流速度储备。
Heart Vessels. 2006 Nov;21(6):350-5. doi: 10.1007/s00380-006-0917-1. Epub 2006 Nov 27.
5
Antiarrhythmic drug cibenzoline attenuates left ventricular pressure gradient and improves transmitral Doppler flow pattern in patients with hypertrophic obstructive cardiomyopathy caused by midventricular obstruction.抗心律失常药物西苯唑啉可减轻由心室中部梗阻引起的肥厚性梗阻性心肌病患者的左心室压力梯度,并改善二尖瓣多普勒血流模式。
Circ J. 2005 Aug;69(8):940-5. doi: 10.1253/circj.69.940.
6
Effect of cibenzoline, a class ia antiarrhythmic agent, on left ventricular diastolic function in hypertrophic cardiomyopathy.Ⅰa类抗心律失常药西苯唑啉对肥厚型心肌病左心室舒张功能的影响。
Cardiovasc Drugs Ther. 2001 Sep;15(5):459-65. doi: 10.1023/a:1013366211927.
7
Effect of cibenzoline on regional left ventricular function in hypertrophic obstructive cardiomyopathy.昔苯唑啉对肥厚性梗阻性心肌病局部左心室功能的影响。
Clin Cardiol. 2000 Sep;23(9):689-96. doi: 10.1002/clc.4960230911.
8
Effect of intravenous administration of cibenzoline on left ventricular diastolic pressures in patients with hypertrophic cardiomyopathy: its relationship to transmitral Doppler flow profiles.静脉注射西苯唑啉对肥厚型心肌病患者左心室舒张压的影响:及其与二尖瓣多普勒血流频谱的关系。
Circ J. 2007 Oct;71(10):1540-4. doi: 10.1253/circj.71.1540.
9
Antiarrhythmic drug, cibenzoline, can directly improve the left ventricular diastolic function in patients with hypertrophic cardiomyopathy.抗心律失常药物西苯唑啉可直接改善肥厚型心肌病患者的左心室舒张功能。
Jpn Circ J. 2001 Jun;65(6):531-8. doi: 10.1253/jcj.65.531.
10
Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline.比较异搏定、吡西卡尼和双苄普林对梗阻性肥厚型心肌病左心室流出道压力阶差的急性降低作用。
Am J Cardiol. 2010 Nov 1;106(9):1307-12. doi: 10.1016/j.amjcard.2010.06.059.

引用本文的文献

1
Contemporary clinical characteristics and management patterns in hypertrophic cardiomyopathy: insights from baseline enrolment data in a nationwide prospective Japanese registry.肥厚型心肌病的当代临床特征与管理模式:来自日本全国前瞻性登记研究基线入组数据的见解
Heart. 2025 Aug 26;111(18):885-892. doi: 10.1136/heartjnl-2024-324811.
2
The clinical utility of cardiac myosin inhibitors for the management of hypertrophic cardiomyopathy: a scoping review.心肌肌球蛋白抑制剂在肥厚型心肌病管理中的临床应用:一项范围综述。
Heart Fail Rev. 2025 Mar;30(2):453-467. doi: 10.1007/s10741-024-10476-w. Epub 2024 Dec 17.
3
A Case of New-Onset Atrial Tachyarrhythmias With Apical Hypertrophic Cardiomyopathy and Bronchiectasis in a Very Elderly Patient: A Therapeutic Dilemma.
一名高龄患者新发房性快速心律失常合并心尖肥厚型心肌病和支气管扩张症:治疗困境
Cureus. 2024 Jun 27;16(6):e63272. doi: 10.7759/cureus.63272. eCollection 2024 Jun.
4
Revisiting Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel Perspectives.肥厚型心肌病的诊断与治疗再探讨:当前实践与新观点
J Clin Med. 2023 Sep 1;12(17):5710. doi: 10.3390/jcm12175710.
5
Reduction of left ventricular pressure gradient due to cibenzoline therapy in a 16-year-old girl with hypertrophic obstructive cardiomyopathy.
J Cardiol Cases. 2022 Aug 4;26(5):341-344. doi: 10.1016/j.jccase.2022.07.009. eCollection 2022 Nov.
6
Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.新型负性肌力药物在症状性梗阻性肥厚型心肌病既定手术心肌切除术时代的未来作用。
J Am Heart Assoc. 2022 May 3;11(9):e024566. doi: 10.1161/JAHA.121.024566.
7
Valvulo-Arterial Impedance and Dimensionless Index for Risk Stratifying Patients With Severe Aortic Stenosis.用于重度主动脉瓣狭窄患者风险分层的瓣膜 - 动脉阻抗及无量纲指数
Front Cardiovasc Med. 2021 Dec 2;8:742297. doi: 10.3389/fcvm.2021.742297. eCollection 2021.
8
Impact of cibenzoline treatment on left ventricular remodelling and prognosis in hypertrophic obstructive cardiomyopathy.西苯唑啉治疗肥厚型梗阻性心肌病对左心室重构和预后的影响。
ESC Heart Fail. 2021 Dec;8(6):4832-4842. doi: 10.1002/ehf2.13672. Epub 2021 Oct 29.
9
Predicting the clinical course in hypertrophic cardiomyopathy using thallium-201 myocardial scintigraphy.使用铊-201心肌闪烁显像术预测肥厚型心肌病的临床病程。
ESC Heart Fail. 2021 Apr;8(2):1378-1387. doi: 10.1002/ehf2.13218. Epub 2021 Feb 12.
10
Takotsubo cardiomyopathy with transient left ventricular obstruction successfully treated with cibenzoline succinate: A case report.琥珀酸西苯唑啉成功治疗伴有短暂性左心室梗阻的应激性心肌病:一例报告
J Cardiol Cases. 2015 Mar 24;11(6):155-157. doi: 10.1016/j.jccase.2015.01.005. eCollection 2015 Jun.